Treatment and prevention of cytomegalovirus in renal transplant patients: weighing the evidence

MeSH terms

• Antiviral Agents / therapeutic use
• Benchmarking
• Cytomegalovirus Infections / drug therapy*
• Cytomegalovirus Infections / etiology
• Cytomegalovirus Infections / prevention & control*
• Evidence-Based Medicine
• Ganciclovir / therapeutic use
• Humans
• Immunoglobulins, Intravenous / therapeutic use
• Infection Control / methods
• Infection Control / standards
• Kidney Transplantation / adverse effects*
• Patient Selection
• Postoperative Care / methods
• Practice Guidelines as Topic
• Risk Factors
• Treatment Outcome